Operating Lease, Right-of-Use Asset in USD of LAVA Therapeutics NV from Q4 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LAVA Therapeutics NV quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2023 to Q1 2025.
  • LAVA Therapeutics NV Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $353K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LAVA Therapeutics NV Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $353K 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $441K -$414K -48.4% 31 Dec 2024 10-Q 06 Nov 2025
Q4 2023 $855K 31 Dec 2023 10-K 28 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.